The overall objective of the Biostatistics Shared Resource (BSR) is to provide Virginia Commonwealth University Massey Cancer Center (MCC) members with expert statistical consultation and collaborative services in support of their basic, translational, and clinical cancer research activities. This objective will be met by providing biostatistical support and guidance to MCC members at all stages of their research including experimental design, sample size requirements and power calculations, study plan development, analysis of the the statistical design, development of randomization and stratification procedures, interim analyses, analysis of completed results, presentation of research findings, and scientific publication to disseminate new findings in the prevention and treatment of cancer. The BSR serves MCC members from all 4 research programs and all cancer center members have access to BSR services. The resource is directed by Kellie J. Archer, PhD, and provides partial support for 7 faculty biostatisticians and one MS biostatistician (2.3 FTEs total). Facility staff are broadly skilled in adaptive study designs for randomized clinical trials, Bayesian and hierarchical modeling, analysis of imaging data, longitudinal data analysis, statistical methods for evaluating diagnostic tests, and analysis of data from high-throughput ?omics platforms. BSR faculty also participate in the oversight of MCC clinical trials and research protocols through the Protocol Review and Monitoring Committee and additionally support the Data and Safety Monitoring Committee. The emphasis on the collaborative nature of the BSR contributes substantially to MCC research by ensuring appropriate biostatistical expertise is available for clinical trial design, basic science study design, and for supporting project development. In addition to collaborating at all levels in research projects, clinical trials, and grant applications, faculty members in the BSR also contribute to cancer-related research by conducting methodological research that applies directly to programmatic research at MCC. They also train investigators through seminars and individual sessions, and educate postdoctoral scientists and clinical fellows through the clinical research and biostatistics graduate degree concentration. The BSR is an MCC-managed resource. MCC members may contact a BSR member anytime by email, and BSR members are available for meetings on campus from 8:00 AM through 5:00 PM Monday through Friday. Ongoing collaboration, exclusive of preparing grant applications, is supported by collaborative grants or contracts, which provides for cost recovery. There are no user fee chares. In CY2015, the BSR provided services to 48 MCC members. The services provided by the BSR add significant value for MCC members as the services are not practically obtained through alternative vendors and very often constitute a tightly integrated component of MCC member?s research studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-38
Application #
9692632
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
38
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Yamada, Akimitsu; Nagahashi, Masayuki; Aoyagi, Tomoyoshi et al. (2018) ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer. Mol Cancer Res 16:1059-1070
Cantwell, Marc T; Farrar, Jared S; Lownik, Joseph C et al. (2018) STAT3 suppresses Wnt/?-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis. Cytokine 111:434-444
Aqbi, Hussein F; Wallace, Matthew; Sappal, Samay et al. (2018) IFN-? orchestrates tumor elimination, tumor dormancy, tumor escape, and progression. J Leukoc Biol :
Volker, Sonja E; Hedrick, Shannon E; Feeney, Yvonne B et al. (2018) Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland. Cancer Res 78:3877-3887
Li, Xiaojiaoyang; Liu, Runping; Huang, Zhiming et al. (2018) Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans. Hepatology 68:599-615
Durant, Stephen T; Zheng, Li; Wang, Yingchun et al. (2018) The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci Adv 4:eaat1719
Damle, S R; Martin, R K; Cockburn, C L et al. (2018) ADAM10 and Notch1 on murine dendritic cells control the development of type 2 immunity and IgE production. Allergy 73:125-136
Wang, Feng; Li, Hongyan; Markovsky, Ela et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget 9:9311-9324
Stokes, Nancy A; Stanciu, Cristina E; Brocato, Emily R et al. (2018) Simplification of complex DNA profiles using front end cell separation and probabilistic modeling. Forensic Sci Int Genet 36:205-212
Poklepovic, Andrew; Qu, Yuesheng; Dickinson, Molly et al. (2018) Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardiooncology 4:

Showing the most recent 10 out of 586 publications